January 5, 2018 · STOCK Act disclosure
Representative Alan S. Lowenthal (Democrat-CA) sold Orexigen Therapeutics, Inc., a stock transaction, valued at $11 - $99. The trade took place on January 5, 2018 and was disclosed on January 23, 2018 (owner: Spouse). Members of Congress must report such transactions within 45 days under the STOCK Act.